ASX-Dividend-Report-Banner

Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care

October 04, 2024 01:18 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care
Image source: Kalkine Media

BANGKOK, Oct. 4, 2024 /PRNewswire/ -- Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission to become a global leader in healthcare. The hospital is focused on expanding its diagnostic expertise across all specialties and strategically uses artificial intelligence (AI) to boost diagnostic speed and accuracy. These advancements contribute to earlier disease diagnosis, a critical factor in treating patients.

Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care
Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care

Siriraj Hospital offers comprehensive imaging modalities, including X-rays, mammograms, CT scans, MRIs, PET-CT, ultrasound, and fluoroscopy, serving a total of 655,389 patients in 2023. The hospital's use of PACs for reporting results, coupled with AI-powered imaging diagnostics, has achieved an accuracy rate of 91.35%. This AI technology, certified by The Royal College of Radiologists of Thailand to be nearly on par with human radiologists (with less than a 5% margin of error), is now being utilized in over 40 hospitals under the Ministry of Public Health.

Siriraj Hospital's laboratory diagnostics encompass hematology, blood chemistry, serology, and molecular diagnostics, including cancer mutation detection for targeted therapies through next-generation sequencing. With the capacity to process over 23,000 tests daily, Siriraj has pioneered the use of an online blood smear imaging system in collaboration with private partners, making it the first hospital in Thailand to fully implement this innovative technology. Moreover, the introduction of allele-specific quantitative PCR in cancer mutation detection has significantly exhibited the promising sign of cancer treatment and reduced reliance on imported reagents, enhancing the affordability and accessibility of these critical tests for patients.

Siriraj operates state-of-the-art parasitology and microbiology labs equipped with 36 advanced scientific instruments, performing an average of 140 tests daily. The hospital's microbiology division includes seven BSL2/BSL2+ biosafety labs, specializing in the analysis of microorganisms, including viruses, bacteria, fungi, mycobacteria, and Toxoplasma parasites. More than 380,000 tests are conducted annually. Siriraj is also home to Thailand's only WASP® automated specimen processing system, the first of its kind in the country.

The hospital's range of genetic diagnostics includes chromosome and DNA analysis for detecting genetic disorders. With over 100 specialized tests, many of which are available at only a few centers nationwide, Siriraj's Molecular Genetics Lab is a leader in the field. The lab's pioneering research has led to the inclusion of BRCA1/2 gene testing for breast cancer patients under the national health insurance scheme.

The Pathology Department at Siriraj is staffed by specialists covering all systems, analyzing around 250 surgical and cytology specimens daily, in addition to 200 special pathology tests. Key services include digital pathology, electron microscopy, and high-precision immunohistochemistry techniques for biomarkers such as ER, PR, HER2, and Ki67.

Siriraj also offers forensic testing services, including drug, toxin, and volatile substance analysis, identity verification, and evidence testing. The hospital's forensic division utilizes 210 highly accurate instruments and conducted 67,514 forensic tests in 2023.

Siriraj Hospital has received multiple international certifications, including ISO 15189 and ISO 15190, and is the first and only teaching hospital in Thailand accredited by the College of American Pathologists (CAP). This recognition reflects the hospital's commitment to delivering medical services that meet the highest global standards.

As one of Thailand's premier medical institutions, Siriraj Hospital is committed to delivering world-class healthcare to patients across the country and throughout the ASEAN region. In addition to its leading role in medical education, Siriraj contributes significant research that drives global advancements in medical science. With over a century of dedication to excellence, Siriraj remains at the forefront of healthcare innovation, continually meeting the standards of the world's top medical institutions.

Contact information:

Faculty of Medicine Siriraj Hospital, Mahidol University

Tel.: +662-419-7000

https://www2.si.mahidol.ac.th/en/ 

About Siriraj Hospital

Established in 1888, Siriraj Hospital is Thailand's oldest and largest healthcare institution, affiliated with the prestigious Faculty of Medicine at Siriraj Hospital, Mahidol University. As a leading specialist referral hospital, it annually trains 300 medical students, fostering the next generation of healthcare professionals. With a capacity of over 2,000 beds, the hospital provides advanced medical services to more than three million patients annually. Its legacy is rooted in a commitment to excellence, compassion, and innovation. Siriraj Hospital continues to be a pillar of healthcare in Thai society, blending tradition with modernity to provide exceptional medical care for the community.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.